| |
| |
|
| Insider
Information: |
Boger Kenneth S |
| Relationship: |
SVP & Chief Legal Offi... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
112,999 |
|
|
Indirect Shares
|
179,188 |
|
|
| Direct
Value |
$49,945,558 |
|
|
|
Indirect Value
|
$79,201,096 |
|
|
| Total
Shares |
292,187 |
|
|
| Total
Value |
$129,146,654 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP & Chief Legal Offi... |
2011-09-13 |
112,999 |
2011-09-13 |
179,188 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-02 |
4 |
A |
$0.01 |
$122 |
D/D |
12,200 |
105,529 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Legal Officer |
• – – |
2011-09-13 |
4 |
AS |
$50.00 |
$1,100,000 |
D/D |
(22,000) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & Chief Legal Officer |
• – – |
2011-09-13 |
4 |
OE |
$18.75 |
$412,500 |
D/D |
22,000 |
134,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2003-11-17 |
4 |
B |
$8.87 |
$47,543 |
D/D |
5,360 |
19,000 |
2.74 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
20,920 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2004-05-06 |
4 |
A |
$0.01 |
$650 |
D/D |
65,000 |
85,920 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2005-02-03 |
4 |
A |
$0.01 |
$57 |
D/D |
5,700 |
91,620 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2007-01-24 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
116,361 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2007-03-30 |
4 |
AS |
$28.08 |
$328,536 |
D/D |
(11,700) |
116,361 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2007-03-30 |
4 |
OE |
$9.07 |
$106,119 |
D/D |
11,700 |
128,061 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2007-04-30 |
4 |
AS |
$31.35 |
$376,200 |
D/D |
(12,000) |
116,361 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2007-04-30 |
4 |
OE |
$10.41 |
$124,920 |
D/D |
12,000 |
128,361 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2007-05-07 |
4 |
AS |
$30.60 |
$388,130 |
D/D |
(12,684) |
103,677 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2008-02-07 |
4 |
A |
$0.01 |
$81 |
D/D |
8,133 |
112,160 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2008-11-18 |
4 |
S |
$26.69 |
$400,350 |
D/D |
(15,000) |
97,517 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-02-05 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
107,683 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-05-07 |
4 |
AS |
$28.89 |
$341,653 |
D/D |
(11,826) |
95,857 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-06-26 |
4 |
AS |
$36.00 |
$3,888,036 |
D/D |
(108,001) |
95,857 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-06-26 |
4 |
OE |
$9.07 |
$1,556,631 |
D/D |
108,001 |
203,858 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-07-28 |
4 |
OE |
$10.41 |
$353,550 |
D/D |
19,898 |
115,755 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2009-07-28 |
4 |
AS |
$36.00 |
$716,328 |
D/D |
(19,898) |
95,857 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2010-02-04 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
106,023 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-02-03 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
116,752 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-03-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(33,333) |
174,167 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & General Counsel |
• – – |
2011-05-02 |
4 |
AS |
$55.57 |
$278,460 |
D/D |
(5,000) |
116,752 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
